Neurology of inherited glycosylation disorders
暂无分享,去创建一个
H. Freeze | E. Eklund | B. G. Ng | M. Patterson | B. Ng
[1] B. Harding,et al. Olivopontocerebellar atrophy of neonatal onset and disialotransferrin developmental deficiency syndrome. , 1991, Archives of disease in childhood.
[2] C. Nordborg,et al. Sural Nerve Pathology in the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .
[3] B. Hagberg,et al. Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders. , 1993, Pediatric neurology.
[4] A. Varki,et al. Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.
[5] T. Miyata,et al. Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. , 1994, The New England journal of medicine.
[6] H. Freeze,et al. Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. , 1996, The Journal of clinical investigation.
[7] E. Mayatepek,et al. Continuous mannose infusion in carbohydrate‐deficient glycoprotein syndrome type I , 1997, Acta paediatrica.
[8] R. Biancheri,et al. Neurophysiological findings in a case of carbohydrate-deficient glycoprotein (CDG) syndrome type I with phosphomannomutase deficiency. , 1998, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[9] C. Adamsbaum,et al. Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1 , 1999, Pediatric Radiology.
[10] Carolyn R. Bertozzi,et al. Essentials of Glycobiology , 1999 .
[11] Gert Matthijs,et al. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic , 2000, Human Genetics.
[12] H. Freeze,et al. Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic. , 2000, Molecular genetics and metabolism.
[13] J. Hofsteenge,et al. Protein C-mannosylation: facts and questions. , 2000, Acta biochimica Polonica.
[14] A. Munnich,et al. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases , 2001, Journal of medical genetics.
[15] D. Krasnewich,et al. Neurologic Course of Congenital Disorders of Glycosylation , 2001, Journal of child neurology.
[16] K. Hwa. Glycosyl phosphatidylinositol-linked glycoconjugates: structure, biosynthesis and function. , 2001, Advances in experimental medicine and biology.
[17] I. Mader,et al. Congenital disorder of glycosylation type Ia: benign clinical course in a new genetic variant , 2002, Child's Nervous System.
[18] S. Kjaergaard,et al. Ophthalmic manifestations of congenital disorder of glycosylation type 1a , 2003, Ophthalmic genetics.
[19] G. Matthijs,et al. Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia. , 2003, Neuropediatrics.
[20] S. Hakomori. Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization , 2004, Glycoconjugate Journal.
[21] J. Hancock. GPI-anchor synthesis: Ras takes charge. , 2004, Developmental cell.
[22] M. Lehrman,et al. Metformin-stimulated Mannose Transport in Dermal Fibroblasts* , 2004, Journal of Biological Chemistry.
[23] O. Bohorov,et al. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.
[24] R. Dwek,et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.
[25] Glycosylation type Ic disorder: idiopathic intracranial hypertension and retinal degeneration , 2005, British Journal of Ophthalmology.
[26] Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient , 2005, American journal of medical genetics. Part A.
[27] R. Houlston,et al. Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency , 2006, Nature Medicine.
[28] I. Pascual-Castroviejo,et al. Ataxia cerebelosa de Norman-Jaeken: Presentación de siete pacientes españoles , 2006 .
[29] J. Vajsar,et al. Walker-Warburg syndrome , 2006, Orphanet journal of rare diseases.
[30] N. Callewaert,et al. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[31] Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation. , 2006, Biochemical and biophysical research communications.
[32] Hudson H. Freeze,et al. Genetic defects in the human glycome , 2006, Nature Reviews Genetics.
[33] G. Matthijs,et al. Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening , 2007, Journal of Neurology.
[34] J. Denecke,et al. A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. , 2007, American journal of human genetics.
[35] Arthur D Lander,et al. Morpheus Unbound: Reimagining the Morphogen Gradient , 2007, Cell.
[36] H. Freeze. Congenital Disorders of Glycosylation: CDG-I, CDG-II, and beyond. , 2007, Current molecular medicine.
[37] Y. Maeda,et al. Targeted therapy for inherited GPI deficiency. , 2007, The New England journal of medicine.
[38] H. Freeze,et al. COG8 deficiency causes new congenital disorder of glycosylation type IIh. , 2007, Human molecular genetics.
[40] D. Krasnewich,et al. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG‐Ia) , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.
[41] M. Krieger,et al. A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. , 2007, Human molecular genetics.
[42] Qing Nie,et al. Computational analysis of BMP gradients in dorsal-ventral patterning of the zebrafish embryo. , 2007, Journal of theoretical biology.
[43] D. Appleton,et al. Congenital disorder of glycosylation type 1a: Three siblings with a mild neurological phenotype , 2007, Journal of Clinical Neuroscience.
[44] B. Galeano,et al. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. , 2007, The Journal of clinical investigation.
[45] J. Gécz,et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. , 2008, American journal of human genetics.
[46] E. Mercuri,et al. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation , 2008, Annals of neurology.
[47] H. Brunner,et al. Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation , 2008, European Journal of Human Genetics.
[48] T. Hennet,et al. On the nomenclature of congenital disorders of glycosylation (CDG) , 2008, Journal of Inherited Metabolic Disease.
[49] Gert Matthijs,et al. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2 , 2008, Nature Genetics.
[50] Laura Vilarinho,et al. Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease. , 2008, Clinical chemistry.
[51] Huilin Li,et al. Structure of the oligosaccharyl transferase complex at 12 A resolution. , 2008, Structure.
[52] H. Ropers,et al. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. , 2008, American journal of human genetics.
[53] J. Esko,et al. Proteoglycans and Sulfated Glycosaminoglycans , 2009 .
[54] Thierry Hennet,et al. Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol‐linked oligosaccharides , 2009, Human mutation.
[55] J. Hofsteenge,et al. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies. , 2009, American journal of human genetics.
[56] Ron A Wevers,et al. Autosomal recessive cutis laxa syndrome revisited , 2009, European Journal of Human Genetics.
[57] R. Morimoto,et al. Biological and chemical approaches to diseases of proteostasis deficiency. , 2009, Annual review of biochemistry.
[58] B. Fernandez,et al. Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival. , 2009, Human molecular genetics.
[59] G. Matthijs,et al. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations. , 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[60] H. Freeze. Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients. , 2009, Biochimica et biophysica acta.
[61] D. Ungar. Golgi linked protein glycosylation and associated diseases. , 2009, Seminars in cell & developmental biology.
[62] J. Dennis,et al. Metabolism, Cell Surface Organization, and Disease , 2009, Cell.
[63] Inka Brockhausen,et al. O-GalNAc Glycans , 2009 .
[64] Matthias Baumgartner,et al. Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation. , 2009, Human molecular genetics.
[65] Other Classes of ER/Golgi-derived Glycans , 2009 .
[66] J. Hewitt. Abnormal glycosylation of dystroglycan in human genetic disease. , 2009, Biochimica et biophysica acta.
[67] S. Grunewald. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). , 2009 .
[68] P. de Lonlay,et al. The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. , 2009, Biochimica et biophysica acta.
[69] Masao Kobayashi,et al. Different neuroradiological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type Ia , 2009, Brain and Development.
[70] W. Annaert,et al. Golgi function and dysfunction in the first COG4-deficient CDG type II patient , 2009, Human molecular genetics.
[71] Sebastian Bauer,et al. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome , 2010, Nature Genetics.
[72] H. Freeze,et al. SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder , 2010, Cell.
[73] J. van Reeuwijk,et al. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism. , 2010, Brain : a journal of neurology.
[74] I. Nishino,et al. A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/ hereditary inclusion body myopathy, a sugar-deficient myopathy: a review , 2010, Therapeutic advances in neurological disorders.
[75] A. Munnich,et al. Posterior fossa imaging in 158 children with ataxia. , 2010, Journal of neuroradiology. Journal de neuroradiologie.
[76] Yukishige Ito,et al. C-Mannosylated peptides derived from the thrombospondin type 1 repeat interact with Hsc70 to modulate its signaling in RAW264.7 cells. , 2010, Glycobiology.
[77] W. Balch,et al. The Proteome in Balance , 2010, Science.
[78] Gert Matthijs,et al. A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report , 2010, Orphanet journal of rare diseases.
[79] R. Pfundt,et al. Skeletal dysplasia with brachytelephalangy in a patient with a congenital disorder of glycosylation due to ALG6 gene mutations , 2010, Clinical genetics.
[80] B. Tseng,et al. Consensus Statement on Standard of Care for Congenital Muscular Dystrophies , 2010, Journal of child neurology.
[81] Florian Gnad,et al. Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints , 2010, Cell.
[82] C. Thiel,et al. Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. , 2010, Human molecular genetics.
[83] H. Takeuchi,et al. Role of glycosylation of Notch in development. , 2010, Seminars in cell & developmental biology.
[84] Liping Yu,et al. O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding , 2010, Science.
[85] A. Afenjar,et al. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations , 2010, Journal of Medical Genetics.
[86] John R Yates,et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. , 2010, Nature chemical biology.
[87] P. Stanley,et al. Roles of glycosylation in Notch signaling. , 2010, Current topics in developmental biology.
[88] N. Senzer,et al. Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. , 2011, Human gene therapy.
[89] Y. Maeda,et al. Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins. , 2011, Progress in lipid research.
[90] H. Freeze,et al. The congenital disorders of glycosylation: A multifaceted group of syndromes , 2006, NeuroRX.
[91] T. Strom,et al. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. , 2011, American journal of human genetics.
[92] Gert Matthijs,et al. How Golgi glycosylation meets and needs trafficking: the case of the COG complex. , 2011, Glycobiology.
[93] Madhuri R Hegde,et al. Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation , 2011, Genetics in Medicine.
[94] B. Choudhury,et al. N-Acetylglucosamine Inhibits T-helper 1 (Th1)/T-helper 17 (Th17) Cell Responses and Treats Experimental Autoimmune Encephalomyelitis* , 2011, The Journal of Biological Chemistry.
[95] K. Campbell,et al. Glycomic Analyses of Mouse Models of Congenital Muscular Dystrophy* , 2011, The Journal of Biological Chemistry.
[96] A. Cideciyan,et al. A missense mutation in DHDDS, encoding dehydrodolichyl diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in Ashkenazi Jews. , 2011, American journal of human genetics.
[97] J. Dennis,et al. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis , 2011, Nature communications.
[98] Susan C. Brown,et al. Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies. , 2011, Current opinion in neurology.
[99] H. Freeze,et al. Golgi glycosylation and human inherited diseases. , 2011, Cold Spring Harbor perspectives in biology.
[100] H. Freeze,et al. Phosphomannose Isomerase Inhibitors Improve N-Glycosylation in Selected Phosphomannomutase-deficient Fibroblasts* , 2011, The Journal of Biological Chemistry.
[101] Carol A. Bocchini,et al. A new face and new challenges for Online Mendelian Inheritance in Man (OMIM®) , 2011, Human mutation.
[102] G. Rechavi,et al. Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN , 2011, Journal of Medical Genetics.
[103] S. Lev,et al. The COG complex interacts directly with Syntaxin 6 and positively regulates endosome-to-TGN retrograde transport , 2011, The Journal of cell biology.
[104] H. Freeze,et al. Pubertal development in ALG6 deficiency (congenital disorder of glycosylation type Ic). , 2011, Molecular genetics and metabolism.
[105] Mild Clinical and Biochemical Phenotype in Two Patients with PMM2-CDG (Congenital Disorder of Glycosylation Ia) , 2012, The Cerebellum.
[106] J. Schuurs-Hoeijmakers,et al. Autosomal Recessive Dilated Cardiomyopathy due to DOLK Mutations Results from Abnormal Dystroglycan O-Mannosylation , 2011, PLoS genetics.
[107] E. Kerem,et al. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. , 2011, American journal of respiratory and critical care medicine.
[108] H. Freeze,et al. Potent, selective, and orally available benzoisothiazolone phosphomannose isomerase inhibitors as probes for congenital disorder of glycosylation Ia. , 2011, Journal of medicinal chemistry.
[109] H. Gröne,et al. Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice , 2011, Nature Medicine.
[110] Rena A. Godfrey,et al. The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases , 2011, Genetics in Medicine.
[111] M. Hegde,et al. Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. , 2012, American journal of human genetics.
[112] M. Hegde,et al. DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation. , 2012, American journal of human genetics.
[113] Linzhao Cheng,et al. The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. , 2012, American journal of human genetics.